MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0069525
Bionor Pharmaceuticals Private Limited
Bionor Pharmaceuticals Private Limited - chemicals in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.56 Lakh
▼ 58% YoY
Net loss · FY 2025
₹13.92 Lakh
Net margin -391.5%
EBITDA · FY 2025
-₹13.47 Lakh
EBITDA margin -378.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Bionor Pharmaceuticals Private Limited
Data last updated:
Bionor Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 04 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2019PTC136562. Its GSTIN is 36AAICB7271R1ZW (Telangana).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Karivedha Santosh Reddy and Akash Muduganti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No.3 – 187 Beside Andhra Bank Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.56 Lakh, a decline of 58% compared to the previous year. For the same year it recorded a net loss of ₹13.92 Lakh (net margin -391.5%) and EBITDA of -₹13.47 Lakh (EBITDA margin -378.9%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 20% over five years.
Bionor Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0069525).
Company details
CIN U24230TG2019PTC136562
Registration Number 136562
Incorporation Date 04 November 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0069525
Recognitions & Rankings of Bionor Pharmaceuticals
Contact details
Bionor Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH. No.3 – 187 Beside Andhra Bank Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Bionor Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Bionor Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bionor Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bionor Pharmaceuticals Private Limited, buy the company report.
Financials of Bionor Pharmaceuticals Private Limited
FY 2025 filings availableBionor Pharmaceuticals Private Limited reported revenue of ₹3.56 Lakh (down 58% YoY) for FY 2025.
Revenue · FY 2025
₹3.56 Lakh ▼ 58%
Net loss · FY 2025
₹13.92 Lakh margin -391.5%
EBITDA · FY 2025
-₹13.47 Lakh margin -378.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 58%
3 years · compounded
▼ 17%
5 years · compounded
▲ 20%
EBITDA CAGR growth
1 year
▲ 8%
3 years · compounded
▼ 39%
5 years · compounded
▼ 36%
Revenue fell 58% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 20%. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹13.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹13.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -378.9% | ||||
| Net Profit Margin | -391.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bionor Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bionor Pharmaceuticals Private Limited
Bionor Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karivedha Santosh Reddy | Director | 04 Nov 2019 | 6 Years 11 Months | Current |
| Akash Muduganti Also directs: Ruscorn Life Sciences Private Limited | Director | 28 Mar 2025 | 1 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Bionor Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bionor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Bionor Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICB7271R1ZW | Telangana | Active | 18 Dec 2019 |
To see the full GST registrations and return filing status of Bionor Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bionor Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Chandra Prakash Jakkula ceased to be Director on 04 Apr 2025.
AGM
Bionor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Chandra Prakash Jakkula ceased to be Director.
Filing
Bionor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Akash Muduganti was appointed as Director.
Appointed
Karivedha Santosh Reddy was appointed as Director.
Incorporation
04 Nov 2019
Bionor Pharmaceuticals Private Limited was registered on 04 Nov 2019 with Roc Hyderabad & aged 6 years 11 months as per MCA records.
Frequently asked questions
Bionor Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 04 November 2019 (7+ years old) and is registered under CIN U24230TG2019PTC136562.
Bionor Pharmaceuticals has 2 current directors:
- Karivedha Santosh Reddy - Director
- Akash Muduganti - Director
The latest financial statements of Bionor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Bionor Pharmaceuticals is 36AAICB7271R1ZW, registered in Telangana.
The CIN (Corporate Identification Number) of Bionor Pharmaceuticals is U24230TG2019PTC136562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bionor Pharmaceuticals was incorporated on 04 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Chandra Prakash Jakkula ceased to be Director on 04 Apr 2025. Akash Muduganti was appointed as Director on 28 Mar 2025. Karivedha Santosh Reddy was appointed as Director on 04 Nov 2019.
Yes, Bionor Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0069525).
The registered office of Bionor Pharmaceuticals is at H. No.3 – 187 Beside Andhra Bank Mayuri Nagar Miyapur, Hyderabad, Telangana, India – 500049.
Bionor Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages